{"id":317404,"date":"2026-10-19T16:02:02","date_gmt":"2026-10-19T10:32:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/tatva-chintan-pharma-chem-q2-results-fy27-pat-21-crore\/"},"modified":"2026-10-19T16:02:02","modified_gmt":"2026-10-19T10:32:02","slug":"tatva-chintan-pharma-chem-q2-results-fy27-pat-21-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/tatva-chintan-pharma-chem-q2-results-fy27-pat-21-crore\/","title":{"rendered":"Tatva Chintan Pharma Chem Q2 Results FY27: PAT Jumps 116.23%, Revenue Rs 217.32 Cr, PAT Rs 21.45 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Tatva Chintan Pharma Chem Q2 Results FY27 were declared on 19 October 2026 as consolidated quarterly results for the July to September 2026 period. Revenue rose 75.94% YoY to Rs 217.32 Cr, while net profit increased 116.23% YoY to Rs 21.45 Cr. The results date, YoY growth and consolidated results together show a stronger reported quarter, with Operating Profit also up 83.12%.<\/p>\n<\/div>\n

Tatva Chintan Pharma Chem Ltd<\/a> (TATVA) Q2 Results FY27 announced on 19 October 2026, covering the company’s financial performance for the July to September 2026 quarter. Tatva Chintan Pharma Chem Q2 Results FY27 showed consolidated revenue of Rs 217.32 Cr versus Rs 123.52 Cr a year earlier, while net profit rose to Rs 21.45 Cr from Rs 9.92 Cr. The results date and consolidated results basis frame the reported numbers clearly.<\/p>\n

Tatva Chintan Pharma Chem Q2 Results present a results analysis built around revenue, the Operating Profit line and net profit, all of which improved on a YoY basis. For investors tracking the chemicals space, the numbers offer a clean reference point for financial highlights, business drivers, outlook and risks, which are covered below in a structured Univest analysis before the table.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n